BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 107662
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.107662
Table 2 Intraoperative considerations for kidney transplantation
Area of management
Anaesthesia considerations
Anaesthesia techniqueGeneral anaesthesia with intubation: Preferred
Neuraxial blocks: Risk of spinal or epidural hematoma
Dose of LA should be reduced
Anaesthesia monitoringMonitoring: Standard ASA monitors (NIBP, SPO2, ECG, ETCO2, temperature)
Arterial line: For beat-to-beat blood pressure monitoring and arterial blood gas analysis, avoided in fistula arm
Central venous catheter: For infusion of induction therapy and vasopressors/inotropes
Fluid managementFluid responsiveness by dynamic indices (SVV or PPV): Target 10%-15%
Crystalloids: Low chloride solutions – preferred to avoid normal saline large doses, risk of hyperkalemia and lactic acidosis with ringer lactate
Colloids: Avoid starches: Risk of coagulopathy, renal injury, routine use of albumin is not recommended
Transfusion managementRed cell transfusions: Transfusion trigger is haemoglobin < 70-80 g/L, Leukoreduced red cell preferred
Fresh frozen plasma/ cryoprecipitate/ platelet: Avoided routinely, if required point of care coagulation monitoring guide suggested
Pain managementMultimodal analgesia and individualized approach: IV paracetamol, fascial plane block, intrathecal morphine, epidural analgesia, skin infiltration with local anaesthetic
Avoid NSAIDS
ImmunosuppressionInduction therapy: Antithymocyte globulin, 1-1.5 mg/kg or basiliximab, 20 mg
IV methylprednisolone (10 mg/kg): 10-15 min before reperfusion of graft
Other interventionsBlood glucose: Target blood sugar 6-10 mmol/L
Temperature: > 35.5 °C, forced air warming device or blankets, fluid warmers
Antibiotic prophylaxis: Cefazolin 2 g IV, 30-60 min before surgical incision
PONV prophylaxis: IV palanosetron 0.075 mg


Write to the Help Desk